Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Wyeth-Ayerst describes antiinflammatory agents

April 2, 1997

Protein Design Labs grants license to IDEC for humanized MAb

March 25, 1997

Antiinflammatory protein described by New York University

March 25, 1997

Fujisawa describes compound for autoimmune diseases

March 24, 1997

Nippon Shinyaku discloses cell adhesion inhibitors

March 21, 1997

JT characterizes novel COX-2 inhibitor

March 19, 1997

COX-2 inhibitors disclosed by Hafslund Nycomed

March 19, 1997

Small, specific inhibitors of VLA4-mediated cell adhesion from Biogen

March 13, 1997

Improved immunomodulating agent described by SKB

March 13, 1997

Cell adhesion inhibitors disclosed by Nippon Shinyaku

March 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...